NHS Regions Impose Two-Year Wait for ADHD and Autism Assessments Amid Funding Strains
England’s National Health Service faces a mounting crisis in neurodiversity care, with at least 15 integrated care boards implementing strict rationing strategies to manage surging demand for attention deficit hyperactivity disorder and autism assessments. Four regional NHS bodies have introduced a minimum two-year waiting period for anyone seeking an evaluation, citing severe budget constraints that leave local health authorities unable to cover mounting assessment costs. Patient advocacy groups have condemned the measures as dangerous and short-sighted, warning that prolonged delays risk harming children’s educational development and leaving vulnerable adults without necessary daily support.
The restrictions emerge as national waiting lists reach staggering heights across England, with 960,000 people currently awaiting an ADHD assessment and another 295,000 waiting for an autism evaluation. To balance their financial books, 15 integrated care boards covering approximately 19 million residents have resorted to capping the number of annual assessments they will fund and applying strict clinical prioritisation criteria to restrict access to individuals displaying the most acute symptoms.
### Regional Variations and Independent Provider Curbs
The impact of these rationing policies varies sharply across England, creating inconsistent access for patients seeking diagnoses. West Yorkshire NHS integrated care board introduced a mandatory two-year waiting time from initial referral for anyone seeking an ADHD or autism assessment with an independent provider. According to the board, the policy was a direct response to its independent assessment bill soaring from £7m in 2023–24 to £21m last year. The West Yorkshire board commissions care for 2.4 million people across Leeds, Bradford, Kirklees, Calderdale, and Wakefield.
Other regions have implemented similarly lengthy delays. Private providers funded by the North East and North Cumbria integrated care board operate under an approximate 78-week minimum waiting time for initial assessments. Somerset integrated care board enforces a 52-week minimum wait, while Devon operates a 14-week delay, and Kent and Medway has also instituted a minimum waiting threshold. Meanwhile, Hampshire and the Isle of Wight restricted ADHD and autism assessments exclusively to patients meeting strict local priority criteria.
### Impact on Patient Choice and Private Healthcare Costs
The implementation of minimum waiting thresholds effectively blocks patients in affected regions from exercising their legal right to choose non-NHS care. Independent clinics currently conduct roughly half of all NHS-funded ADHD assessments and a third of those for autism, acting as a crucial release valve for overextended health services.
By enforcing minimum waits that prevent timely referrals to independent providers, the NHS policies leave individuals with few options. Patients who can afford out-of-pocket expenses are increasingly forced to pay private providers directly for assessments, which can cost several thousand pounds.
Charities and patient advocacy groups have sharply criticized the measures. The charity ADHD UK denounced the minimum waits as heartless and dangerous. Representatives from patient groups warn that administrative barriers preventing timely diagnoses will severely damage children’s prospects at school, deny adults essential management tools, and increase long-term risks such as suicide.
### Pending Government Review and Surging Prevalence Data
The disclosure of widespread assessment rationing precedes the publication of a major government-commissioned review examining the colossal increase in mental health, ADHD, and autism diagnoses in recent years. Wes Streeting, the then health secretary, ordered the investigation last year amid concerns that surging demand was overwhelming health service capacity. Led by Professor Peter Fonagy, the 700-page report was unexpectedly postponed from its scheduled release.
Ahead of its publication, sources familiar with the document indicate it highlights how rising demand has left patients reliant on a private sector characterized by variable assessment quality and financial incentives linked to diagnostic activity. Data provided by the Clinical Practice Research Datalink and cited in the review reveal a dramatic generational rise in diagnoses. The prevalence of autism among boys aged seven to 18 surged from 0.2% in 2000 to 4.7% by 2025, while prevalence among boys aged six to 11 climbed from 0.4% to 6.3%. Similarly, ADHD diagnoses among boys aged seven to 18 rose from 0.4% to 5.1% over the same quarter-century span.
Keep reading